Tuesday, March 17, Wednesday, March 18, 2015
|
|
- Rosaline Taylor
- 7 years ago
- Views:
Transcription
1 KEY: PRE CONFERENCE SYMPOSIUM Sponsored Symposium Symposium Plenary Lecture Other Event *Pre-registration is required for the Informal Networking with Professor Lunch Session Tuesday, March 17, 2015 Hermes 08:00-15:00 14:30-17:00 PRE CONFERENCE SYMPOSIA - Neuropathology Workshop (Registration Required) PRE CONFERENCE SYMPOSIA - Imaging Satellite (Registration Required) (9:00-15:00) Wednesday, March 18, :30-10:30 ADVANCED CHARACTERIZATION OF EARLY DISEASE STAGE APP PROCESSING, ABETA AND SECRETASES PROFILING DLB, PD and FTD METABOLISM 1 10:30-11:00 Posters and Coffee 11:00 13:00 NEURODEGENERATIVE DISEASES CAN STANDARDIZATION IMPROVE THE PREDICATIVE VALUE OF ANIMAL MODELS? (PODIUM DISCUSSION) ALPHA-SYNUCLEIN:PATHOLOGICAL MECHANISMS LipiDiDiet - NUTRITIONAL INTERVENTION IN PRODROMAL AD CSF AND IMAGING BIOMARKERS OF AD 13:00 14:00 Lunch, Posters & Informal Networking with Professors* 14:00 16:00 PROPAGATION OF TAU-PATHOLOGY INFLAMMATION 1 UPDATE ON TREATMENT OF PD MITOCHONDRIA 16:00 16:30 Posters and Coffee STRESS AND TELOMERE MAINTENANCE MECHANISMS IN HUMAN LIFE TRAJECTORIES Elizabeth H. Blackburn, USA 16:30 18:00 THE CONCEPT OF SUBCONSCIOUSNESS IN ALZHEIMER AND PARKINSON DISEASES Yves Agid, France THE PRION MODEL AS A GUIDE DIAGNOSIS AND THERAPY OF TAUOPATHIES Marc Diamond, USA 18:00-18:15 Short 18:15 19:15 Opening Ceremony 19:15 Welcome Reception in the Exhibition Area
2 Thursday, March 19, 2015 Hermes HOW DO WE TREAT ALZHEIMER'S DISEASE A DECADE BEFORE DEMENTIA? Reisa Sperling, USA PROTEIN FOLDING, MISFOLDING AND DEGRADATION GENETICS 1 AMYLOID PRODUCTION AND ABETA TOXICITY TRANSLATIONAL STRATEGIES 1: ABETA TARGETS Exhibition, Posters, Lunch & Informal Networking with Professors* NEURONAL NETWORKSAND SYNAPTIC FUNCTION EPIGENETICS AND GENETIC MECHANISMS TAUOPATHIES 1 DISEASE MECHANISMS TRANSLATIONAL STRATEGIES 2: NUTRITION, TAU TARGETS 17:15-19:15 SEEDING, SPREADING, AND PRION-LIKE MECHANISMS TRANSLATIONAL STRATEGIES 3: CHOLINERGIC TARGETS, STEM CELLS AND GROWTH FACTORS ANIMAL MODELS - NEW WAYS TO GO? BIOMARKERS 2: PD AND LBD
3 Friday, March 20, 2013 OPTICAL DECONSTRUCTION OF FULLY-ASSEMBLED BIOLOGICAL SYSTEMS Karl Deisseroth, USA AMYLOID-REDUCING THERAPIES IN ALZHEIMER S DISEASE BIOMARKERS AND MRI 1 POTENTIAL NOVEL BIOMARKERS Exhibition, Posters, Lunch & Informal Networking with Professors ER STRESS, SIGMA-1 RECEPTORS AND GPCRS AS THERAPEUTIC TARGETS IN CNS DISEASES APP BIOLOGY 1 PET 1: TAU IMAGING BIOMARKERS 3 17:15-19:15 PRESENILIN BIOLOGY TRANSLATIONAL STRATEGIES 4: Gsk3BETA, TAU TARGETS (2) PET 2: AMYLOID AND RECEPTORS APOE: MECHANISMS AND APOE-BASED TREATMENT STRATEGIES 19:15-19: :15 Conference Educational Lecture: Art and Life - A Spiritual Journey (A lecture about Marc Chagall's way to represent a symbolic and an ethereal vision of the world)
4 Saturday, March 21, 2015 NEUROPROTECTIVE APPROACHES IN PARKINSON S DISEASE EXPLORED IN ALPHA-SYNUCLEIN OVEREXPRESSION MODELS Anders Björklund, Sweden MECHANISMS AND THERAPEUTIC STATEGIES IN ALS/FTD SPECTRUM DISEASES MRI 2 PROTEIN MODIFICATION AND DEGRADATION Exhibition, Posters, Lunch & Informal Networking with Professors DEMENTIA WITH LEWY BODIES: UPDATES FROM PRE-CLINICAL AND CLINICAL STUDIES, PART I TAU BIOLOGY AND DISEASE MECHANISMS 1 TDP 43, C9ORF72 AND TTR FUNCTIONS OF ETA SECRETASE AND BACE1 17:15-19:15 TAU IMMUNOTHERAPY PINK1, LRRK AND PARKIN VASCULAR ASPECTS OF NEURODEGENERATION SYNUCLEIONOPATHIES AND PRION DISEASES 19:15-20:15 20:15 ADPD Network Event
5 Sunday, March 22, 2015 ALZHEIMER S DISEASE: FROM PRECLINICAL STATES TO DEMENTIA Bruno Dubois, France MICROGLIA AND INNATE IMMUNITY UPDATE ON DLB:CLINICAL AND PRE- CLINICAL STUDIES (PART 2) RETROMERS IN AD AND PD TAU BIOLOGY AND DISEASE MECHANISMS 2 Coffee 11:45-13:45 CLINICAL TRIALS PODIUM DISCUSSION Is there a way to increase the chance of success in Phase 3? OTHER TREATMENT STRATEGIES TAU BIOLOGY AND DISEASE MECHANISMS 3 INFLAMMATION 2 13:45 14:15 Closing Ceremony
Program. Society for Neuroscience Satellite Event. November 6-8 th 2013 San Diego, USA
Alzheimer s Disease Workshop: Alzheimer s Disease Research From Different Perspectives Program Society for Neuroscience Satellite Event November 6-8 th 2013 San Diego, USA The Internationale Stichting
More informationMCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease
MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can
More informationPREDICTION AND PREVENTION OF DEMENTIA: NEW HOPE SECOND INTERNATIONAL MEETING OF THE MILAN CENTER (NEUROMI) MILAN, JULY 6-8, 2016 FOR NEUROSCIENCE
www.neuromi.it SECOND INTERNATIONAL MEETING OF THE MILAN CENTER FOR NEUROSCIENCE (NEUROMI) PREDICTION AND PREVENTION OF DEMENTIA: NEW HOPE MILAN, JULY 6-8, 2016 Consiglio Nazionale delle Ricerche A new
More informationNormal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD
Normal and Abnormal Aging and the Brain Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD The myth of cognitive decline The myth of cognitive decline Individual change varies Individual change varies
More informationPROMISING NEW TREATMENTS FOR ALZHEIMER S TARGET MULTIPLE DISEASE-RELATED PROTEINS, MAY HAVE BENEFITS FOR SEVERAL BRAIN DISEASES
CONTACT: Alzheimer s Association AAIC newsroom, 202-249-4002, media@alz.org Niles Frantz, Alzheimer s Association, 312-363-8782, niles.frantz@alz.org PROMISING NEW TREATMENTS FOR ALZHEIMER S TARGET MULTIPLE
More informationStroke & Alzheimer s Disease: An Inflammatory Duo
Stroke & Alzheimer s Disease: An Inflammatory Duo Stroke and Dementia One in 3 will experience a stroke, dementia or both 64% of persons with a stroke have some degree of cognitive impairment and up to
More informationPrimary Endpoints in Alzheimer s Dementia
Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in
More informationComplement in human disease, September 8th - 12th 2017
Complement in human disease, September 8th - 12th 2017 www.emchd2017.dk Copenhagen, Denmark venue Hotel Scandic Copenhagen september 8th - 12th 2017 Vester Søgade 6, 1601 COMPLEMENT IN HUMAN DISEASE 2017
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationHarnessing the power of precision medicine to treat Alzheimer s and ALS February, 2016
Harnessing the power of precision medicine to treat Alzheimer s and ALS February, 2016 2 Forward looking statement: safe harbor This slide deck may contain certain forward-looking information. Such information
More informationRESEARCHERS REPORT NEW WAYS TO PREDICT THE DEVELOPMENT OF ALZHEIMER S DISEASE
CONTACT: Alzheimer s Association AAIC newsroom, 202-249-4002, media@alz.org Niles Frantz, Alzheimer s Association, 312-363-8782, niles.frantz@alz.org RESEARCHERS REPORT NEW WAYS TO PREDICT THE DEVELOPMENT
More informationMonday, August 25, 2014
Danish Dementia Research Centre, Copenhagen University Kristian Steen Frederiksen, MD, PhD; Danish Dementia Research Centre, Copenhagen University Danish Dementia Research Centre, Copenhagen University
More informationXXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective. May 11 12; 2015
XXVIIII Annual Meeting Danish Society for Neuroscience (DSfN) Stem Cells in a Neurotranslational Perspective May 11 12; 2015 Hotel Hesselet, Nyborg Symposium organizers Morten Blinkenberg, University of
More informationDiseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University
Diseases of the Nervous System Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University Outline A. Stress-related Disorders 1. Emotional Circuitry: Key Components 2. The Hypothalamic
More informationSupport Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
More informationNEUROINFLAMMATION IN CNS DISORDERS: PRIMING A TARGET FOR NEW THERAPIES
INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (10) Decima scuola estiva di Neuroscienze (10) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL
More informationFixture List 2018 FIFA World Cup Preliminary Competition
Fixture List 2018 FIFA World Cup Preliminary Competition MATCHDAY 1 4-6 September 2016 4 September Sunday 18:00 Group C 4 September Sunday 20:45 Group C 4 September Sunday 20:45 Group C 4 September Sunday
More informationNEUROSCI 373/ PSY 279 Behavioral Neuroimmunology: Brain and Behavior in Health and Disease Fall 2012
NEUROSCI 373/ PSY 279 Behavioral Neuroimmunology: Brain and Behavior in Health and Disease Fall 12 PROFESSOR: Dr. Staci D. Bilbo, PhD, Assistant Professor of Psychology & Neuroscience Office Hours: By
More information1 in 3 seniors dies with Alzheimer s or another dementia.
2013 Alzheimer s disease facts and figures Includes a Special Report on long-distance caregivers 1 in 3 seniors dies with Alzheimer s or another dementia. Out-of-pocket expenses for long-distance caregivers
More informationCruise Line Agencies of Alaska. Cruise Ship Calendar for 2016 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL
Cruise Line Agencies of Alaska Cruise Ship Calendar for 2016 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL Page 1 of 5 Sunday, May 1 07:0-18:0 Monday, May 2 Tuesday, May 3 Wednesday, May 4 Thursday,
More informationThe Genetic Basis of Neurological Disorders
The Genetic Basis of Neurological Disorders A complete advanced undergraduate/graduate course with: 22 online lectures by leading authorities Resources for workshops, tutorials, journal clubs, projects
More informationCruise Line Agencies of Alaska. Cruise Ship Calendar for 2016 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL
Cruise Line Agencies of Alaska Cruise Ship Calendar for 06 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL 6: Friday, April 5, 06 Cruise Line Agencies of Alaska, Cruise Ship Calendar for 06 Page
More information2014 Alzheimer s Disease Facts and Figures
2014 Alzheimer s Disease Facts and Figures Includes a Special Report on Women and Alzheimer s Disease Almost two-thirds of Americans with Alzheimer s disease are women. Alzheimer s Disease is the six eading
More informationSandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE
Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE L Ignoto, il Mistero, stimolano il pensiero, sono indispensabili al poeta ed all artista, aprono alla creatività. L Ignoto, il Mistero,
More informationCholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
More informationWIPO Summer Schools on Intellectual Property
E SUMMER SCHOOL WIPO/ACAD//14/INF.1 ORIGINAL: ENGLISH DATE: JANUARY 2014 WIPO Summer Schools on Intellectual Property organized by the World Intellectual Property Organization (WIPO) in cooperation with
More informationHow To Navigate Early-Stage Alzheimer s Disease
How To Navigate Early-Stage Alzheimer s Disease PRODUCED BY What We Can Expect Unless there is a cure, over the next 20 years, as Baby Boomers turn 65, the age after which Alzheimer s disease becomes most
More informationUnmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
More information30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
More informationOctober 13, 2014. Signature Programs
Signature Programs October 13, 2014 Neuroscience The goal of the neuroscience initiative is to create a nationally recognized center of research into the biological bases of brain function and dysfunction
More informationPARKINSON S DISEASE MULTIPLE DOMAINS
PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (5) Quinta scuola estiva di Neuroscienze (5) July 7-13, 2007 PARKINSON S DISEASE MULTIPLE DOMAINS Catania Parco degli
More informationANXIETY, DEPRESSION AND NEURODEGENERATIVE DISEASES: NOVEL RESULTS IN THE DISCOVERY OF THEIR PATHOMECHANISMS AND NOVEL DRUG CANDIDATES
ANXIETY, DEPRESSION AND NEURODEGENERATIVE DISEASES: NOVEL RESULTS IN THE DISCOVERY OF THEIR PATHOMECHANISMS AND NOVEL DRUG CANDIDATES Botond Penke University of Szeged September 25, 2008. NEUROBIOLOGICAL
More informationThe 2014 Harvard / Paul F. Glenn. Symposium on Aging. June 23, 2014
The 2014 Harvard / Paul F. Glenn Symposium on Aging June 23, 2014 The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Welcome to the Harvard/Paul F. Glenn Symposium on Aging at Harvard
More informationInternational Conference on Medical Rehabilitation and Prevention of Blindness. November 27 th 29 th, 2015 TENTATIVE SCIENTIFIC PROGRAM
International Conference on Medical Rehabilitation and Prevention of Blindness November 27 th 29 th, 2015 TENTATIVE SCIENTIFIC PROGRAM Pre conference workshop Nov 27 th, 2015 (Friday) Room: Chao Praya2,3,4
More informationHEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.
HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE Field Name Description Translational Research Mortality Analysis Join University-Conselleria Unit for Translational Research in the health
More informationJohns Hopkins Memory & Alzheimer s Treatment Center
Memory is The Memory Center has not only provided great care to my husband, but also has helped me learn to care for myself while caring for him. - Sylvia Mackey Have you forgotten someone s name you should
More information2015 Alzheimer s Disease Facts and Figures
2015 Alzheimer s Disease Facts and Figures Includes a Special Report on Disclosing a Diagnosis of Alzheimer s Disease Alzheimer s Disease is the sixth-leading cause of death in the United States. more
More informationPredicting the future progression of dementia. Ashish Raj, PhD
Business Presentation Predicting the future progression of dementia Ashish Raj, PhD Founder and CEO Associate Professor of Computer Science in Radiology Director, IDEAL Laboratory Associate Professor of
More informationClinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
More informationRetinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease
Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Eleonora (Nora) Lad, MD, PhD Assistant Professor of Ophthalmology, Vitreoretinal diseases Duke Center for Macular Diseases Duke University
More informationTranslational research facilitating experimental medicine in dementia in the UK
Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June
More informationGYMR A4 Study Long Form Film
VIDEO INTRO GRAPHICS GRAPHIC DR. SPERLING AUDIO 0:00 [Music & Graphics Only] 0:05 The A4 Study is a landmark clinical trial to prevent the memory loss associated with Alzheimer s disease. 0:10 Thank you
More informationInternational Conference of the Korean Society for Molecular and Cellular Biology
International Conference of the Korean Society for Molecular and Cellular Biology Oct. 21 (Tue) ~ 23 (Thu), 2014 Korean Society for Molecular and Cellular Biology www.visitkorea.or.kr www.ksmcb.or.kr October
More informationGraduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine. Graduate Certificate. Metabolic & Nutritional Medicine
Graduate and Postdoctoral Affairs School of Biomedical Sciences College of Medicine Graduate Certificate in Metabolic & Nutritional Medicine Graduate Certificate Metabolic & Nutritional Medicine Purpose
More informationRoche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
More informationUPDATE ON ALZHEIMER'S DISEASE CLINICAL TRIALS
UPDATE ON ALZHEIMER'S DISEASE CLINICAL TRIALS Laurie Ryan, PhD Program Director, Alzheimer s Disease Clinical Trials Dementias of Aging Branch Division of Neuroscience National Institute on Aging, National
More informationMagnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic
More informationCruise Line Agencies of Alaska. Cruise Ship Calendar for 2012 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL
Cruise Line Agencies of Alaska Cruise Ship Calendar for 0 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL :8 Tuesday, January 0, 0 Cruise Line Agencies of Alaska, Cruise Ship Calendar for 0 Page
More informationBiomarkers for Alzheimer's Disease in Down Syndrome
Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers
More informationGene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press
Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction
More informationEVT Execute & EVT Innovate World-class drug discovery
EVT Execute & EVT Innovate World-class drug discovery Evotec AG, First Quarter Report 2015, 12 May 2015 Forward-looking statements Information set forth in this presentation contains forward-looking statements,
More informationCruise Line Agencies of Alaska. Cruise Ship Calendar for 2013 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL
Cruise Line Agencies of Alaska Cruise Ship Calendar for 0 FOR PORT(S) = KTN AND SHIP(S) = ALL AND VOYAGES = ALL 9:5 Friday, January 0, 0 Cruise Line Agencies of Alaska, Cruise Ship Calendar for 0 Page
More informationAgeing Research in Trinity College
Ageing Research in Trinity College 1. Trinity College Institute of Neuroscience & partner hospitals and centres Trinity s ageing research is carried out primarily by researchers affiliated to the Trinity
More informationPROGRAMME NORDIC CONGRESS IN CLINICAL BIOCHEMISTRY
PROGRAMME 1. april 2016 2016 BASIC AND TRANSLATIONAL RESEARCH LAB ORGANISATION DISEASE ENTITIES BREAKS & SOCIAL EVENTS TUESDAY 14 JUNE 2016 14.00-16.00 Registration HCA 16.00-16.15 Opening ceremony Carl
More informationOverview of Phase 1 Oncology Trials of Biologic Therapeutics
Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of
More informationNeurological Disorders Summit
Neurological Disorders Summit July 2015 06-08 San Francisco USA Welcome Message United Scientific Group takes great pleasure in inviting you to participate at the Neurological Disorders Summit (), July
More informationJornada Informativa en Bioeconomía. Retos Colaboración 2016
Jornada Informativa en Bioeconomía. Retos Colaboración 2016 Novel Multifunctional Nanoplatform as Theranostic Technology for the Alzheimer Disease. NANOTHERAD autor: María del Carmen Dona MD PhD PROPOSAL:
More informationParticipating in clinical research. Martha A. Nance MD Hennepin County Medical Center HD Center of Excellence Struthers Parkinson s Center
Participating in clinical research Martha A. Nance MD Hennepin County Medical Center HD Center of Excellence Struthers Parkinson s Center Presenter Disclosures Martha Nance The following personal financial
More informationIADR/Unilever Hatton Awards Competition - Judges Room. IADR/Unilever Hatton Awards Competition SENIOR (Basic BH, Sala Ipe II
IADR GENERAL SESSION, Iguacu Falls, Brazil June 18-23, 2012 Date Time Title Location Monday, June 18 8 a.m. - 4 p.m. International Consensus Workshop: Expanded TMD Taxonomy for Further Classification Research
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More informationTHE ROLE OF GENETICS AND ENVIRONMENT IN PARKINSON S DISEASE Marco Baptista, PhD Associate Director, Research Programs
THE ROLE OF GENETICS AND ENVIRONMENT IN PARKINSON S DISEASE Marco Baptista, PhD Associate Director, Research Programs MJFF MISSION AND APPROACH MJFF IS THE WORLD S LARGEST NONPROFIT FUNDER OF PD RESEARCH
More informationHUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE
HUNTINGTON S DISEASE MULTIDISCIPLINARY CLINIC HUNTINGTON S DISEASE THERAPIES RESEARCH UPDATE From gene to treatments The gene that causes Huntington s disease (HD) was discovered in 1993. Since then, enormous
More informationGENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110
GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED207.110 COVERAGE: Pre- and post-genetic test counseling may be eligible for coverage in addition to the genetic
More information2016 Programs & Information
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
More informationLocal Clinical Trials
Local Clinical Trials The Alzheimer s Association, Connecticut Chapter does not officially endorse any specific research study. The following information regarding clinical trials is provided as a service
More informationLCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH
LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International
More informationAlzheimer s & Dementia 7 (2011) 280 292
Alzheimer s & Dementia 7 (2011) 280 292 Toward defining the preclinical stages of Alzheimer s disease: Recommendations from the National Institute on Aging-Alzheimer s Association workgroups on diagnostic
More informationScandinavian Bio-Business Seminar, Zürich. Presentation 10 February 2016 Håkon Sæterøy, CEO
Scandinavian Bio-Business Seminar, Zürich Presentation 10 February 2016 Håkon Sæterøy, CEO Clinical need 75 m patients WW A global estimate of 75m patients with Mild Cognitive Impairment (MCI) who may
More informationGE Global Research. The Future of Brain Health
GE Global Research The Future of Brain Health mission statement We will know the brain as well as we know the body. Future generations won t have to face Alzheimer s, TBI and other neurological diseases.
More informationPh.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
More information58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement
SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA ABSTRACT DEADLINE May 2, 2016 First Announcement Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Local Scientific Committee Vincenzo
More information2016 ALZHEIMER S DISEASE FACTS AND FIGURES
2016 ALZHEIMER S DISEASE FACTS AND FIGURES Includes a Special Report on the Personal Financial Impact of Alzheimer s on Families About this report 2016 Alzheimer s Disease Facts and Figures is a statistical
More informationAlzheimer s disease. What is Alzheimer s disease?
Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible
More informationJ D R F R E Q U E S T S L E T T E R S O F I N T E N T F O R : B I O M AR K E R S O F P AN C R E A T I C B E T A C E L L S T R E S S AN D H E AL T H
J D R F R E Q U E S T S L E T T E R S O F I N T E N T F O R : B I O M AR K E R S O F P AN C R E A T I C B E T A C E L L S T R E S S AN D H E AL T H PURPOSE JDRF, the world s leading non-profit organization
More informationA Cure for Alzheimer s Disease by 2025? The case against.
1 A Cure for Alzheimer s Disease by 2025? The case against. Dr. Howard Feldman Professor of Neurology Faculty of Medicine University of British Columbia Vancouver 2 Disclosure Consulting, lectures and
More informationCEN Outreach Neurological Disorders
CEN Outreach Neurological Disorders Migraine, Mul,ple Sclerosis, Alzheimer s Disease Migraine Migraine is the most common neurological disorder in the developed world Almost 1 in 5 Americans will have
More informationCRITERIA FOR AD DEMENTIA June 11, 2010
CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester
More informationINTERNATIONAL RESEARCH GRANT PROGRAM ANNOUNCEMENT FISCAL YEAR 2016 JUNE 2016 PROGRAM (March 2016 August 2016)
INTERNATIONAL RESEARCH GRANT PROGRAM ANNOUNCEMENT FISCAL YEAR 2016 JUNE 2016 PROGRAM (March 2016 August 2016) I. BACKGROUND: ASSOCIATION MISSION AND SCIENTIFIC AGENDA...2 II. AREAS OF FOCUS FOR THE JUNE
More informationCollaborative Network Award Planning Grants Project Summaries
Collaborative Network Award Planning Grants Project Summaries PRIORITY AREA: Projects that will drive development of one or more pre-clinical drug candidates through identification and validation of molecular
More informationMonday Tuesday Wednesday Thursday Friday Saturday Sunday. Day 4 20-Minute Aerobics Solution. Day 3 Lower Body Weight Training
Your -Week -for-life Schedule Week Week Week 3 Week Week Week Week Week Week Week Week Week Monday Tuesday Wednesday Thursday Friday Saturday Sunday Day Day Day Day Day Day 3 Day 3 Day Day Day Day Day
More informationA leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
More information5th International Advanced ICAS Training Course on "Blood Stem Cell Transplantation: State of the Arts, Methods and Perspectives" 22-25 June 2009
International Center for Advanced Studies in Health Sciences and Services (ICAS) of the Medical Faculty, University of Ulm Germany http://icas.uni-ulm.de 5th International Advanced ICAS Training Course
More informationGUIDELINES FOR FUTURE SITES FOR ISPPD CONGRESSES GUIDELINES FOR APPLICATIONS TO HOST THE ISPPD CONGRESS 2020
GUIDELINES FOR APPLICATIONS TO HOST THE ISPPD CONGRESS 2020 1 I. INTRODUCTION 1. The International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) holds its congress every two years late in
More informationMetabolomics - Measuring Metabolic Adaptation
Metabolomics - Measuring Metabolic Adaptation MERIT Skill Training 3 11. 17.3.2013 Organizers Thomas Nägele, Ella Nukarinen and Wolfram Weckwerth Department Molecular Systems Biology University of Vienna
More informationFASEB Directory of Members Online
Head, Department of Anatomy and Radiology The College of Veterinary Medicine at the University of Georgia invites nominations and applications for the position of Head of the Department of Anatomy and
More informationALS CANADA BRAIN CANADA ARTHUR J. HUDSON TRANSLATIONAL TEAM GRANTS
In partnership with En collaboration avec ALS CANADA BRAIN CANADA ARTHUR J. HUDSON TRANSLATIONAL TEAM GRANTS ALS Canada, Brain Canada and Federal Government Partnership Make Largest Investment in Canadian
More information"GRANITIC PEGMATITES: THE STATE OF THE ART"
"GRANITIC PEGMATITES: THE STATE OF THE ART" Porto (Portugal), May 6-12, 2007 Organized by University of Porto, Porto, Portugal University of the Basque Country, Bilbao, Spain LMTG, Observatoire Midi Pyrénées,
More informationStem cells and motor neurone disease
Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and how they may be used to create
More informationINVITATION. 48th Annual Scientific Meeting of the European Society for Clinical Investigation. 30 April - 3 May 2014 Utrecht, the Netherlands
INVITATION 48th Annual Scientific Meeting of the European Society for Clinical Investigation 30 April - 3 May 2014 Utrecht, the Netherlands Dear colleagues, It is a great pleasure to host this prestigious
More informationCachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.
REPORT Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F. Strasser, CH 13-14 March 2015 Barcelona, Spain The Conference Cachexia
More informationThe Sheraton Harrisburg Hershey PRS Annual Meeting
CORPORATE SUPPORT INFORMATIONAL PACKET 2 nd Annual Scientific Meeting September 26 27, 2015 The Sheraton Harrisburg/Hershey Pennsylvania Rheumatology Society Corporate Support Details 2 nd Annual Scientific
More informationUC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine
UC Davis Institute for Regenerative Cures A facility supported by the California Institute for Regenerative Medicine Naming Opportunities Opportunity No. Description/Features Gift Amount Institute for
More informationStem Cells Market Trends based on Primary Industry Analysis
GENReports: Market & Tech Analysis Stem Cells Market Trends based on Primary Industry Analysis > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us > Gary Oosta,
More informationCognitive-Communication Disorders of Dementia
Cognitive-Communication Disorders of Dementia Definition, Diagnosis, and Treatment Second Edition Kathryn A. Bayles, PhD, CCC-SLP Cheryl K. Tomoeda, MS, CCC-SLP Contents Preface Acknowledgements Contributors
More informationAldersforskning. Prosjektkatalog
Aldersforskning Prosjektkatalog Innhold: COURSE AND NEUROBIOLOGY OF NEUROPSYCHIATRIC SYMPTOMS IN PARKINSON'S DISEASE; AND INTERVENTION TO PREVENT USE OF RESTRAINT AND BEHAVIOUR...1 ROLE OF SCAVENGER CELLS
More informationSupporting and Caring for Persons with. Intellectual and Developmental Disabilities: Ethical Reflections & Practical Recommendations
International Association of Catholic Bioethicists (IACB) 6 th International Colloquium Supporting and Caring for Persons with Intellectual and Developmental Disabilities: Ethical Reflections & Practical
More informationI N V E S T O R P R E S E N TAT I O N B I O T R I N I T Y L o n d o n A p r i l 2 0 1 6
I N V E S T O R P R E S E N TAT I O N B I O T R I N I T Y L o n d o n A p r i l 2 0 1 6 DISCLAMER This document has been prepared by Oryzon Genomics, S.A. exclusively for use during the presentation. Oryzon
More informationSeminar/Talk Calendar
Seminar/Talk Calendar Tuesday, February 3rd Dr. John Neumaier, Professor of Psychiatry and Pharmacology, University of Washington DREADDing Addiction Dr. Neumaier s laboratory is studying stress and addiction
More informationRoche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from three Phase III studies of the
Media Release Basel, 12 April 2016 Roche to present new data at AAN showing superior efficacy of investigational medicine ocrelizumab versus comparators on disease activity and progression in two forms
More informationNo. Acronym Full Title Institution Department Elegibility Note. Department of Molecular and Translational Medicine
3 LightingPD Light-Induced Neurodegeneration, an Innovative Approach to Model Parkinson s Disease Universty of L'Aquila Biotechnological and Applied Clinical Sciences Department 3 LightingPD Light-Induced
More information